Barinthus Biotherapeutics (BRNS)
NASDAQ: BRNS
· Real-Time Price · USD
1.13
0.03 (2.54%)
At close: Aug 20, 2025, 3:42 PM
1.14
0.88%
After-hours: Aug 20, 2025, 04:10 PM EDT
Barinthus Biotherapeutics Revenue
Barinthus Biotherapeutics reported an annual revenue of $14.97M, reflecting a 1766.46% growth. For the quarter ending March 31, 2025, Barinthus Biotherapeutics generated $0 in revenue.
Revenue (ttm)
14.97M
Revenue Growth
1766.46%
Price / Sales Ratio
3.18
Revenue / Employee
142.56K
Employees
105
Market Cap
45.59M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | % Change |
---|---|---|
Dec 31, 2024 | 14.97M | +1766.46% |
Dec 31, 2023 | 802K | -98.21% |
Dec 31, 2022 | 44.7M | +16580.22% |
Dec 31, 2021 | 268K | -94.44% |
Dec 31, 2020 | 4.82M | -29.86% |
Dec 31, 2019 | 6.87M | n/a |